Zentalis Pharmaceuticals, Inc. (ZNTL)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
5. 11
+0.54
+11.8162%
$
339.56M Market Cap
- P/E Ratio
- Div Yield
3.55M Volume
-3.66 Eps
$ 4.57
Previous Close Want to track ZNTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zentalis Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 94,854 | $128,053.37 | $439,174.02 | $311,120.65 | 242.96% |
 Arthur Mallet Regency Capital Management Inc.\DE | 29,500 | $519,102 | $137,765 | -$381,337 | -73.46% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 16,700 | $39,078 | $77,571.5 | $38,493.5 | 98.5% |
 Lindsey Seagraves Carson Advisory Inc. | 23,270 | $119,090.2 | $110,881.55 | -$8,208.65 | -6.89% |
| DP Drew Phillips Fortitude Family Office LLC | 209 | $489 | $977.07 | $488.07 | 99.81% |
 Corey Saft Sivia Capital Partners, LLC | 20,000 | $27,000 | $90,700 | $63,700 | 235.93% |
 Dan Wohlgemuth 49 WEALTH MANAGEMENT, LLC | 66,401 | $94,793.58 | $300,464.52 | $205,670.94 | 216.97% |
| PLC Peapod Lane Capital LLC Peapod Lane Capital LLC | 366,868 | $582,487.78 | $1.85M | $1.27M | 218.38% |
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 22,447 | $35,690.73 | $111,554.86 | $75,864.13 | 212.56% |
